alexa Use of Blood-based mRNA profiling to Identify Biomarker
ISSN: 2161-0932

Gynecology & Obstetrics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Use of Blood-based mRNA profiling to Identify Biomarkers for Ovarian Cancer Screening

Samuel C Mok1*, Jae-Hoon Kim2, Steven J Skates3, John O Schorge3, Daniel W Cramer4, Karen H Lu1, Choong-Chin Liew4

1The University of Texas M. D. Anderson Cancer Center, Houston, TX

2Yongdong Severance Hospital, Yonsei University College of Medicine, Youngdong, Seoul, Korea

3Massachusetts General Hospital, Harvard Medical School, Boston, MA

4Formerly Visiting Professor of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

*Corresponding Author:
Dr. Samuel C Mok
Department of Gynecologic Oncology and Reproductive Medicine
University of Texas M. D. Anderson Cancer Center T4.3908
1515 Holcombe Boulevard, Houston, TX 77030
Tel: 713-792-1442
Fax: 713-792-1459
E-mail: [email protected]

Received date: June 22, 2017; Accepted date: June 28, 2017; Published date: June 30, 2017

Citation: Mok CS, Kim JH, Skates SJ, Schorge JO, Cramer DW, et al. (2017) Use of Blood-based mRNA profiling to Identify Biomarkers for Ovarian Cancer Screening. Gynecol Obstet (Sunnyvale) 7:443. doi: 10.4172/2161-0932.1000443

Copyright: © 2017 Mok CS, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Purpose: To identify candidate genomic signatures for the early detection of ovarian cancer using whole bloodbased gene expression profiles.

Experimental Design: We performed Affymetrix U133Plus 2.0 GeneChip microarray analyses on whole blood RNA samples obtained from 14 ovarian cancer patients and 15 age-matched, healthy women. Genes differentially expressed were identified using a parametric Welch t-test. Real-time qRT-PCR analyses were performed on RNA prepared from 96 ovarian cancer patients and 83 age-matched healthy women, using primer sets specific for 14 genes. A Mann Whitney U test assessed individual gene significance. CA125 levels were determined in the same set of samples. We used logistic regression analyses and cross validation to assess the ability of linear combinations of specific transcripts combined with CA125 to distinguish cancer from controls.

Results: Microarray analyses showed that 9583 probes were significantly different in blood gene expression profiles from healthy women as compared with those from ovarian cancer patients (p<0.05). Real-time RT-PCR analyses on the 96 cases and 83 controls validated 7 genes, which showed significantly different expression levels in cases and controls. Logistic regression analyses and cross validation identified an optimal panel of markers including CA125, BRCA1, and KIAA0562, that could improve the sensitivity of CA125 alone to over 90% at 98% specificity in the detection of early stage ovarian cancer.

Conclusion: Circulating blood gene expression profiles identified RNA markers that can improve the sensitivity of CA125 in the detection of early stage ovarian cancer. Further validation is warranted to confirm the clinical usefulness of these biomarkers.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords